MARC record from Internet Archive

LEADER: 02020cam a22003734a 4500
001 398508
005 20070130092921.0
008 050915s2006 inu b s001 0 eng
010 $a 2005027198
035 $a61692698
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dUKM$dC#P$dIG#$dFVC$dBTCTA
015 $aGBA618655$2bnb
016 7 $a101257289$2DNLM
016 7 $a013391216$2Uk
020 $a0253347483
024 3 $a9780253347480
042 $apcc
043 $an-us---
050 00 $aHD9666.5$b.W43 2006
060 00 $a2006 F-240
060 10 $aQV 736$bW374p 2006
049 $aXIMM
100 1 $aWeber, Leonard J.,$d1942-
245 10 $aProfits before people? :$bethical standards and the marketing of prescription drugs /$cLeonard J. Weber.
260 $aBloomington :$bIndiana University Press,$cc2006.
300 $a206 p. ;$c24 cm.
440 0 $aBioethics and the humanities
504 $aIncludes bibliographical references (p. [185]-197) and index.
505 0 $aEthics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better.
520 $aIncludes information on advertising, conflicts of interest, cost of pharmaceuticals, direct to consumer advertising, advertising to patients, Pfizer, pricing of pharmaceuticals, profit motive, samples of pharmaceuticals, etc.
650 0 $aPharmaceutical industry$xMoral and ethical aspects$zUnited States.
650 0 $aMarketing$xMoral and ethical aspects$zUnited States.
650 20 $aPharmaceutical industry$xEconomics$zUnited States.
994 $aC0$bXIM